Ionis to hold third quarter 2024 financial results webcast

IONS 10.23.2024

Full Press ReleaseSEC FilingsOur IONS Tweets

About Gravity Analytica

Recent News

    Recent Filings

    • 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
    • 01.16.2025 - 144 Report of proposed sale of securities

    Webcast scheduled forWednesday, November 6at11:30 a.m. Eastern Time

    CARLSBAD, Calif.,Oct. 23, 2024/PRNewswire/ --Ionis Pharmaceuticals, Inc.(Nasdaq: IONS) announced today that it will host a live webcast onWednesday, November 6that11:30 a.m. Eastern Timeto discuss its third quarter 2024 financial results.

    Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

    The webcast may be accessed athttps://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.

    AboutIonis Pharmaceuticals, Inc.For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visitIonis.comand follow us onX (Twitter)andLinkedIn.

    Ionis Pharmaceuticals Investor Contact:D. Wade Walke, Ph.D. –IR@ionis.com– 760-603-2331

    Ionis Pharmaceuticals Media Contact:Hayley Soffer –media@ionis.com– 760-603-4679

    CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-third-quarter-2024-financial-results-webcast-302283732.html

    SOURCEIonis Pharmaceuticals, Inc.

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com